Sagian Equity

Scott Atkin and Tim Bruemmer are the sole principals and investment decision-makers. Both are serial technology entrepreneurs who co-founded the firm after exiting multiple companies. The firm's own website lists the two as its entire team, and it has not disclosed any investment committee beyond the two named founders.

Sagian states that it leverages its founders' networks and thrives on collaboration. Given Scott Atkin and Tim Bruemmer's history as repeat operators with multiple exits — including sales to Allergan, John Deere, and strategic acquirers in the industrial and healthcare sectors — their deal flow is likely operator-referral and network-driven rather than dependent on intermediaries or banker-led processes.

The firm has not disclosed any outside limited partners or committed fund structures. Its principals present the firm as an extension of their own entrepreneurial track record, and all public materials describe personal operator capital rather than a blind pool. Until a fundraise or LP disclosure appears, Sagian should be treated as a proprietary-capital vehicle.

Sagian's public portfolio and stated investment philosophy point to enterprise software, industrial technology, and agri-foodtech as core areas. One portfolio company sold to John Deere in 2023, confirming an agricultural-technology position; the founders' prior exits also span healthcare technology and SaaS, indicating additional exposure to digital health and enterprise software.

Sagian has not publicly disclosed its check-size range or its posture on leading rounds. Its website describes a structured approach that aims to reduce risk without placing an unnecessary burden on entrepreneurs, which is consistent with a flexible early-stage participant rather than a price-setting lead. No co-investment partners have been named in its materials.